NTRR Begins Clinical Trials of Enhanced Weight-Loss Formula
Neutra Corp. (OTCBB:NTRR), an emerging nutraceuticals provider, is
pleased to announce that clinical trials are now underway on its new and
improved weight-loss supplement, Pure Plus Weight Loss.
The trials will be the first human testing performed on the all-natural
supplement since the addition of raspberry ketone and African mango, two
hot new fat-burners that have seen demand grow by leaps and bounds since
being recommended by TV’s Dr. Oz. These powerful new ingredients, along
with others, have been infused with Bio-Energy to dramatically increase
the supplement’s potency as a pure and natural weight-loss weapon.
Volunteers will test the supplement by taking a single dose once a day.
One group will test the regular Pure Plus formulation and the other
group will be given the supplement with the addition of the sub-atomic
Bio-energy infusion. Neither group will know which of the formulas they
have received. The trials will take 60 days to complete and results will
be compiled within 30 days after testing concludes.
Once testing and analysis are complete, NTRR will begin plans for the
retail launch of Pure Plus. The revolutionary supplement will be the
first in a product line of superior, all-natural nutraceuticals that the
company is working to offer consumers as quickly as possible.
Neutra Corp. is developing Pure Plus and other new products to compete
in the fast-growing nutraceuticals industry alongside Herbalife Ltd.
(NYSE: HLF), Vitamin Shoppe (NYSE: VSI), Nutraceutical International
Corp. (NASDAQ: NUTR) and Schiff Nutrition International Inc. (NYSE: WNI).
is a healthy lifestyle company that specializes in the development and
marketing of nutritional supplements, nutrient boosters, herbal remedies
and other natural wellness solutions. The company is currently working
to produce a full range of products to address every component of a
healthy lifestyle, including muscle building, weight loss and general
wellness through a daily nutrition regimen. For investing information
and performance data, please visit www.neutracorp.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information
included herein for events occurring after the date hereof.